NightHawk Biosciences Q2 EPS $(0.53) Down From $(0.40) YoY, Sales $700.00K Up From $50.98K YoY
Portfolio Pulse from Benzinga Newsdesk
NightHawk Biosciences reported Q2 losses of $(0.53) per share, a 32.5% decrease YoY. However, the company's sales increased by 1.27K% to $700.00K from $50.98K YoY.
August 14, 2023 | 9:08 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
NightHawk Biosciences reported a YoY decrease in EPS but a significant increase in sales.
The company's EPS has decreased YoY, which could negatively impact the stock. However, the significant increase in sales could offset this negative impact, leading to a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100